Photodynamic therapy and anti-tumour immunity

Ana P. Castano; Pawel Mroz; Michael R. Hamblin

doi:10.1038/nrc1894

Photodynamic therapy and anti-tumour immunity

Ana P. Castano, Pawel Mroz, Michael R. Hamblin

Research output: Contribution to journal › Review article › peer-review

2266 Citations (Scopus)

Abstract

Photodynamic therapy (PDT) uses non-toxic photosensitizers and harmless visible light in combination with oxygen to produce cytotoxic reactive oxygen species that kill malignant cells by apoptosis and/or necrosis, shut down the tumour microvasculature and stimulate the host immune system. In contrast to surgery, radiotherapy and chemotherapy that are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, invasion and infiltration of the tumour by leukocytes, and might increase the presentation of tumour-derived antigens to T cells.

Original language	English
Pages (from-to)	535-545
Number of pages	11
Journal	Nature Reviews Cancer
Volume	6
Issue number	7
DOIs	https://doi.org/10.1038/nrc1894
Publication status	Published - Jul 2006
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nrc1894

Cite this

@article{d01bf5e9e7db40319c95ed00294f6a13,

title = "Photodynamic therapy and anti-tumour immunity",

abstract = "Photodynamic therapy (PDT) uses non-toxic photosensitizers and harmless visible light in combination with oxygen to produce cytotoxic reactive oxygen species that kill malignant cells by apoptosis and/or necrosis, shut down the tumour microvasculature and stimulate the host immune system. In contrast to surgery, radiotherapy and chemotherapy that are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, invasion and infiltration of the tumour by leukocytes, and might increase the presentation of tumour-derived antigens to T cells.",

author = "Castano, {Ana P.} and Pawel Mroz and Hamblin, {Michael R.}",

year = "2006",

month = jul,

doi = "10.1038/nrc1894",

language = "English",

volume = "6",

pages = "535--545",

journal = "Nature Reviews Cancer",

issn = "1474-175X",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Photodynamic therapy and anti-tumour immunity

AU - Castano, Ana P.

AU - Mroz, Pawel

AU - Hamblin, Michael R.

PY - 2006/7

Y1 - 2006/7

N2 - Photodynamic therapy (PDT) uses non-toxic photosensitizers and harmless visible light in combination with oxygen to produce cytotoxic reactive oxygen species that kill malignant cells by apoptosis and/or necrosis, shut down the tumour microvasculature and stimulate the host immune system. In contrast to surgery, radiotherapy and chemotherapy that are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, invasion and infiltration of the tumour by leukocytes, and might increase the presentation of tumour-derived antigens to T cells.

AB - Photodynamic therapy (PDT) uses non-toxic photosensitizers and harmless visible light in combination with oxygen to produce cytotoxic reactive oxygen species that kill malignant cells by apoptosis and/or necrosis, shut down the tumour microvasculature and stimulate the host immune system. In contrast to surgery, radiotherapy and chemotherapy that are mostly immunosuppressive, PDT causes acute inflammation, expression of heat-shock proteins, invasion and infiltration of the tumour by leukocytes, and might increase the presentation of tumour-derived antigens to T cells.

UR - http://www.scopus.com/inward/record.url?scp=33745537921&partnerID=8YFLogxK

U2 - 10.1038/nrc1894

DO - 10.1038/nrc1894

M3 - Review article

C2 - 16794636

AN - SCOPUS:33745537921

SN - 1474-175X

VL - 6

SP - 535

EP - 545

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

IS - 7

ER -

Photodynamic therapy and anti-tumour immunity

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this